# How to Write a Process Design Basis That Actually Gets Used
A Process Design Basis (PDB) is the most critical document in any pharmaceutical or chemical engineering project. It serves as the single source of truth that translates laboratory chemistry, regulatory cGMP constraints, and safety limits into concrete engineering design data. It defines the boundaries within which the plant's piping, instrumentation, vessels, and control systems will be sized and built.
Unfortunately, many PDBs end up gathering dust on office shelves because they are either too generic, lack critical operating envelopes, or fail to address the unique containment and cleanliness requirements of pharmaceutical manufacturing. In this guide, we establish a structured, pharma-focused framework for writing a PDB that downstream engineers will actively consult.
# 1. The Process Design Basis Workflow
A PDB acts as a bridge between R&D chemistry and physical plant layout. It compiles raw material inputs, containment limits, and utility assumptions to output detailed engineering drawings:
# 2. Core Sections of a Pharma-Chemical PDB
To be highly functional, a Process Design Basis for a pharmaceutical facility must cover five core engineering pillars:
# Pillar 1: Process Chemistry & Stoichiometric Mass Balance
This section translates the laboratory-scale synthetic recipe into commercial batch scales. It must define:
- Stoichiometric Charge Ratios: Exact molar ratios of reactants and reagents, identifying limiting reagents.
- Intermediate Yield Targets: Expected yield percentages and purity criteria at each step.
- Solvent Density & Vapor Pressures: Multi-temperature physical properties of all process solvents (e.g., methanol, toluene, THF) to enable pump and relief valve sizing.
- Solvent Recovery Goals: Targets for distillation and recycling of organic solvents to minimize environmental impact.
# Pillar 2: Critical Process Parameters (CPPs) & Envelopes
Rather than specifying single nominal operating values, the PDB must document the allowable range of operating envelopes:
- Critical Temperature Ranges: The normal operating temperature range (e.g., 75°C to 80°C), the maximum allowable temperature limit (e.g., 85°C) to prevent thermal degradation, and the minimum temperature to prevent crystallization.
- Dosing Rates and Timings: Minimum and maximum addition rates for reactants (e.g., dosing 500 Liters of reactant over 60 minutes) to manage exothermic heat loads.
- Agitation Requirements: Minimum power-per-volume ratios (W/m3) and impeller tip speeds to guarantee suspension of catalysts or liquid-liquid dispersion.
# Pillar 3: Regulatory & cGMP Compliance
Pharmaceutical design is governed by strict sanitary requirements. The PDB must establish:
- Material of Construction (MOC): Specified by corrosion risk (e.g., 316L Stainless Steel for general solvent service, Hastelloy C-22 for acidic mixtures, or Glass-lined Steel).
- Surface Finish (Ra): Maximum surface roughness limits (typically Ra less than or equal to 0.4 micrometers, electropolished) for product-contact surfaces to prevent residue buildup.
- Cleanability Targets (CIP/SIP): Assumptions for Clean-in-Place (CIP) systems (minimum fluid velocities of 1.5 m/s, spray ball coverage of 60 to 90 L/min per meter of vessel perimeter) and Steam-in-Place (SIP) thermal cycles (maintaining 121°C for 30 minutes at drainage lines).
# Pillar 4: Safety & Occupational Exposure Banding (OEB)
Modern pharma facilities process highly potent active pharmaceutical ingredients (HPAPIs). Sizing containment requires:
- OEB Containment Limits: Defining the target exposure limits (e.g., OEB 4: 1 to 10 micrograms/m3, or OEB 5: less than 1 microgram/m3) which dictates the use of closed glovebox isolators or split butterfly valves.
- Dust Explosion Hazards: Standardizing powder safety values including Minimum Ignition Energy (MIE) in millijoules and deflagration index (Kst) in bar-meter/second to design explosion vents on filter-dryers.
- Inertization Parameters: Specifying nitrogen purging cycles (e.g., reducing oxygen concentration to less than 2% by volume before organic charging) to prevent electrostatic explosions.
# Pillar 5: Utility Interface Assumptions
Utility loads must be estimated using clear scale factors to avoid under-sizing plant headers:
- Water Systems: Target consumption rates for Purified Water (PW) and Water for Injection (WFI) in Liters/minute.
- Thermal Utilities: Glycol coolant cooling duty in kilowatts (kW) and clean steam pressure requirements (typically 3.0 bar g).
- Instrument Air & Nitrogen: Peak volume demands in normal cubic meters per hour (Nm3/h) during batch transfer steps.
# 3. Operational Cycle Times & Facility Throughput
A common mistake when compiling a Process Design Basis is ignoring the operational hold times and quality control (QC) testing cycles. These parameters directly restrict the bottleneck cycle time of the product, limiting the overall facility throughput.
# 3.1. Quality Control (QC) Testing Timelines
Every intermediate and final drug substance batch must undergo QC clearance testing before being transferred to downstream steps or packaged for release. The PDB must document:
- Raw Material & Intermediate Hold Times: Typical testing turnaround times (e.g., HPLC purity assay, GC residual solvent analysis, Karl Fischer water content) can range from 12 hours to 48 hours. If the process produces an intermediate batch every 24 hours, the plant must design a minimum of two holding tank volumes to store material while waiting for QC lab approval.
- Sterility & Microbiological Assays: For sterile drug substances, testing times can extend up to 14 days. This requires significant temperature-controlled warehouse space for raw inventory storage and quarantine hold areas.
# 3.2. Unit Operation Separation & Hold Times
Separation steps are often the primary bottlenecks of a production line. The PDB must detail:
- Crystallization Hold & Aging Profiles: Time required for crystal nucleation, growth, and temperature drop (often 4 to 12 hours) to avoid poor crystalline forms and low filtration rates.
- Phase Separation Settle Times: During liquid-liquid extractions, the time needed for the organic and aqueous layers to fully settle (e.g., 2 to 4 hours) determines the decanting timeline and sizing margins of phase separators.
- Filtration Washing & Cake Deliquoring: Wash volumes (expressed in cake-volumes) and gas blow-through durations required to lower solvent residue before drying.
- Vacuum Drying Profiles: The drying cycle duration (e.g., 8 to 24 hours in a double-cone vacuum dryer) to achieve the target LOD (Loss on Drying) without thermal product degradation.
# 3.3. Facility Capacity Sizing Equation:
To size equipment capacities, engineers calculate the target throughput using this plain-text balance:
Annual Capacity = (365 days * Operating Factor * Batch Size) / Cycle Time
Where:
- Operating Factor: Sized at 0.85 (accounting for 15% downtime for preventive maintenance and cleaning validation).
- Cycle Time: The duration of the bottleneck step (often drying or filtration separation, including QC hold times).
# 4. Best Practices: Writing a PDB That Downstream Engineers Use
- Segregate Facts from Assumptions: Clearly tag assumptions (e.g., "Utility temperature assumed at 5°C pending site verification") with a tracking register to prevent downstream design drift.
- Provide the 'Why' behind Constraints: If a temperature must stay below 45°C, note the chemical reason (e.g., "To prevent degradation of intermediate compound X"). This prevents future operators or designers from modifying control limits.
- Standardize on Metric Units: Ensure all engineering dimensions, flow rates, and pressures are strictly metric to align with international safety design calculations.
- Include a Document Change Log: Track version changes, especially during R&D transitions, to ensure the entire engineering team is aligned on the latest batch recipe.
# 5. Reference Guidelines
- ISPE Baseline Guide: Volume 5 - Commissioning and Qualification.
- ISPE Baseline Guide: Volume 1 - Active Pharmaceutical Ingredients.
- FDA Guidance for Industry: Q8(R2) Pharmaceutical Development.
# 🛠️ Interactive Engineering Tool
To perform calculations related to this topic, access our interactive engineering tool: Unit Converter.
# Applicable Engineering Standards & Codes Used
The engineering methodologies, design correlations, and safety criteria detailed in this article adhere to the following international standards and industry codes:
- ASME B31.3: Process Piping Code
- API RP 14E: Recommended Practice for Design and Installation of Offshore Production Platform Piping Systems
- Hydraulic Institute Standards (HI 1.3, HI 2.3) for Centrifugal and Positive Displacement Pumps: Hydraulic Institute Standards (HI 1.3, HI 2.3) for Centrifugal and Positive Displacement Pumps
- ISO 5167: Measurement of Fluid Flow by Means of Pressure Differential Devices